Search clinical trials for: CL-009

Total 3033 results

Genocea Biosciences, Inc.

Completed

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

Renal Cell Carcinoma | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Urothelial Carcinoma | Cutaneous Melanoma

United States
Octapharma

Completed

Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs)

Severe Hemophilia A

United States, Bulgaria
Can-Fite BioPharma

Completed

A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver Disease

Non-alcoholic Steatohepatitis (NASH)

Israel
University of Castilla-La Mancha

Recruiting

Spinal Muscular Atrophy on Wheels, Using Power Mobility (SMAPmob)

Spinal Muscular Atrophy

Spain
Indiana University

Recruiting

Coronary Collaterals and Post-reperfusion Intramyocardial Hemorrhage (MIRON-CL)

Acute Myocardial Infarction

United States
Institute of Tropical Medicine, Belgium
University of Gondar; Boru Meda Hospital

Completed

Outcomes of Complicated CL in Ethiopia Treated With Miltefosine

Cutaneous Leishmaniases

Ethiopia
University of California, San Diego

Completed

Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients

Hormone Replacement Therapy | Renal Function | Transgender

United States
Chengyi Sun

Unknown

Contrastive Study for Minimally Invasive Cholecystolithotomy With Gallbladder Reservation and Laparoscopic Cholecystectomy

Gallstones

China
Cloudbreak Therapeutics, LLC
Novotech (Australia) Pty Limited

Completed

Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop

Myopia, Progressive

Australia
Celgene

Completed

ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies

Solid Tumors

United States
Biogen

Completed

GER-009-06-AVX Early Therapy in Multiple Sclerosis (FIT)

Relapsing-Remitting Multiple Sclerosis
Sanofi

Completed

Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra Inj.) in Subjects Aged 3 Years Old and Above

Influenza

Korea, Republic of
Boehringer Ingelheim

Completed

Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Japanese Patients With COPD

Pulmonary Disease, Chronic Obstructive

Japan
University of Edinburgh

Completed

Edinburgh and Lothian Virus Intervention Study in Kids (ELVIS Kids)

Pediatric ALL | Upper Respiratory Tract Infections | Virus | Virus Shedding

United Kingdom
Aadi Bioscience, Inc.

Active, not recruiting

ABI-009, an mTOR Inhibitor, for Patients With Severe Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States
National University of Malaysia

Completed

Performance of Red Tinted Contact Lenses on Colour Defects (CL)

Color Vision Defects | Color Blindness

Malaysia
BioProtect

Completed

Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)

Prostate Cancer

United States
Royal United Hospitals Bath NHS Foundation Trust
University of Oxford; Biotronik SE & Co. KG; University of Bath; RUHX (Official...

Recruiting

Super-Rehab: a Novel Approach to Reverse Atrial Fibrillation (SuRe-AF)

Atrial Fibrillation | Overweight and Obesity

United Kingdom
Contextual Change LLC

Completed

Mindfulness and Acceptance Applied in Colleges Through Web-Based Guided Self-Help (Phase II)

Mental Health

United States
Institut Cancerologie de l'Ouest

Completed

Anesthesia Feasibility Study With the CONCERT-CL® Station (CONCERT)

Cancer | Surgery

France
Boehringer Ingelheim

Completed

WAL 801 CL Dry Syrup in Pediatric Atopic Dermatitis Patients

Dermatitis, Atopic
Boehringer Ingelheim

Completed

Investigation of the Metabolism and Pharmacokinetics of [14C]BI 1744 CL and [14C]BI 1744 CL Administered as an Oral Solution in Healthy Male Subjects

Healthy
Global Alliance for TB Drug Development

Completed

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)

Pulmonary Tuberculosis
Boehringer Ingelheim

Completed

WAL 801 CL Dry Syrup in Paediatric Atopic Dermatitis Patients

Dermatitis, Atopic
Memorial Sloan Kettering Cancer Center

Completed

CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Multiple Myeloma

United States
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Mono Products of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers

Healthy
Johns Hopkins University

Completed

Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder

Alcoholism | Alcohol Related Disorders

United States
Boehringer Ingelheim

Completed

Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Liver Diseases | Healthy
Alaxia SAS

Terminated

Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients

Bronchiectasis | Cystic Fibrosis

France
Octapharma

Completed

Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A

Severe Hemophilia A

Germany, Austria, United Kingdom, Bulgaria
Sanofi

Completed

A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With Vandetanib (Vandetanib)

Healthy

United States
Morphotek

Completed

An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer

Pancreatic Cancer

United States, Canada, Spain, Belgium, Germany
U.S. Army Medical Research and Development Command
InBios International, Inc.

Completed

Evaluation of CL Detect™ Rapid Test to Detect Cutaneous Leishmaniasis

Skin Diseases

United States
Sun Yat-sen University

Unknown

Laparoscopic Surgery Versus Radiofrequency Ablation for Recurrent HCC

Hepatocellular Carcinoma
Compass Therapeutics

Recruiting

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Cholangiocarcinoma | Biliary Tract Cancer | Gall Bladder Cancer | Ampullary Cancer

United States
University of Aberdeen

Active, not recruiting

Effect of FISH Intake on MEtabolic Health in a Diabetic South Asian popuLation (FISH MEAL) (FISHMEAL)

Diabetes Mellitus, Type 2

United Kingdom
Boehringer Ingelheim

Completed

Bioequivalence of the New Formulation of WAL 801 CL Dry Syrup Compared to the Conventional Formulation of WAL 801 CL Dry Syrup in Healthy Male Volunteers

Healthy
University of Nottingham
Unilever R&D

Completed

Effects of Omega-3 Fatty Acids Supplementation on Brain and Behaviour in Healthy Children.

Behaviour

United Kingdom
Boehringer Ingelheim

Completed

Single Rising Peroral Doses of BI 1744 CL in Healthy Volunteers

Healthy
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Preventing Hypoglycemia During Exercise With Proactive Snacking on Closed Loop

Type 1 Diabetes

United States
Bio-K Plus International Inc.
Sprim Advanced Life Sciences

Completed

Efficacy and Safety Study in the Prevention of Antibiotic-Associated Diarrhea (AAD) and Clostridium Difficile-Associated Diarrhea (CDAD) in Hospitalized Adult Patients Exposed to Nosocomial Infection

Clostridium Difficile-Associated Diarrhea | Antibiotic-Associated Diarrhea
UCB BIOSCIENCES, Inc.

Completed

Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome

Restless Legs Syndrome

United States
Aadi Bioscience, Inc.

Recruiting

Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer

Cancer | Endometrial Cancer | Tumor | Recurrent Endometrial Carcinoma | Endometrioid Endometrial Cancer | Endometrioid Tumor

United States
Merck Sharp & Dohme LLC

Withdrawn

MK-5475 in Participants With Hypoxemia Due to COVID-19 Pneumonia (MK-5475-009)

Pneumonia | Coronavirus Disease 2019 (COVID-19) | Hypoxemia
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Olaparib Plus Pembrolizumab Versus Chemotherapy Plus Pembrolizumab After Induction With First-Line Chemotherapy Plus Pembrolizumab in Triple Negative Breast Cancer (TNBC) (MK-7339-009/KEYLYNK-009)

Triple Negative Breast Neoplasms

Colombia, United States, Canada, Chile, France, Germany, Hungary, Ireland, Japan, Korea, Republic of, Poland, Spain, Taiwan, Ukraine, United Kingdom
Zagazig University

Completed

Two Institutes Experience in Laparo-Endoscopic Rendezvous Technique for Gallbladder and Bile Duct Stones

Calculus; Gallbladder, With Cholecystitis
Sanofi

Completed

Postmarketing Surveillance Study for Quadrivalent Influenza Vaccine (VaxigripTetra®) in Subjects Aged 6 to 35 Months

Influenza

Korea, Republic of
UCB Pharma

Completed

Rotigotine Versus Placebo As Double Blind Study To Evaluate The Efficacy In Early Stage Idiopathic Parkinson's Disease Patients

IDIOPATHIC PARKINSON'S DISEASE

China
Aadi Bioscience, Inc.
National Cancer Institute (NCI)

Completed

Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer (NMIBC)

United States

3

Subscribe